Peking University Third Hospital, Chigenovo Co. describe therapies including CYP4V2 and RdCVF June 28, 2021 No Comments
Applied Genetic Technologies reports 12-month data from phase I/II achromatopsia trials June 25, 2021 No Comments
Gemini reports data from ongoing phase IIa study on GEM-103 in GA secondary to dry AMD June 23, 2021 No Comments
Positive safety data reported from cohort 1 of OASIS study evaluating CLS-AX in wet AMD June 16, 2021 No Comments
EyeGate begins phase II proof-of-concept study of PP-001 for ocular surface inflammation June 15, 2021 No Comments
Stuart initiates patient enrollment in phase II study of ST-100 for dry eye disease June 14, 2021 No Comments
RSS